CL

Colgate-Palmolive Company 10-K Summary (Fiscal Year Ended Dec 31, 1994)

Business Context and Reporting Period

This Annual Report (Form 10-K) covers the fiscal year ended December 31, 1994. Colgate-Palmolive Company is a global manufacturer and marketer of consumer products organized into two primary segments: Oral, Personal and Household Care, and Specialty Marketing (primarily Hill's Pet Nutrition). The Company operates in over 60 countries with 301 facilities worldwide. As of February 28, 1995, there were 144,579,030 shares of Common Stock outstanding.

Key Financial Metrics

Material Changes vs. Prior Period

• Revenue Growth: Worldwide net sales increased 6% to $7,587.9 million. Excluding disposed non-core businesses, sales grew 8% driven by 7% volume growth. Strong growth occurred in Asia/Africa (+20%) and Latin America (+14%), while North America declined 8% due to trade downstocking and disinflationary pricing.
• Profitability: Net income rose significantly to $580.2 million from $189.9 million in 1993. The 1993 figure was depressed by a one-time $358.2 million charge for accounting standard changes. Excluding accounting changes and a $5.2 million charge for the sale of Princess House in 1994, income increased 7% year-over-year.
• Segment Performance: The Oral, Personal and Household Care segment saw EBIT rise 9%. Specialty Marketing EBIT increased 10%, led by Hill's Pet Nutrition.
• Capital Structure: The debt-to-total capitalization ratio increased to 52% from 48% in 1993, driven by debt incurred for share repurchases and acquisitions.

Guidance, Outlook, and Risks

• Outlook: Management expects positive momentum to continue in 1995, particularly in developing markets. The acquisition of Kolynos (South America) is expected to drive growth, though economic uncertainty in Mexico may temper near-term results.
• Subsequent Event: On January 10, 1995, the Company acquired the Kolynos oral care business for $1,040.0 million in cash. This is expected to have a dilutive effect of less than 5% on first-year earnings.
• Risks and Contingencies:
  • Legal/Environmental: The Company paid a $110,000 penalty to the EPA regarding wastewater violations at its Jeffersonville, Indiana plant. A citizen's suit was filed, but management believes the ultimate disposition will not materially impact financial condition.
  • Regulatory: The Kolynos acquisition is subject to antitrust review in Brazil and Colombia.
  • Market: Raw material prices (e.g., tallow, essential oils) are subject to wide variation. Foreign currency fluctuations impact results, though hedging strategies are employed.
• Capital Allocation: The Company repurchased 6.9 million shares for $411.1 million in 1994. Dividends per common share increased to $1.54 (up from $1.34 in 1993).

Investor Verification Checklist

• Accounting Adjustments: Verify the impact of the 1993 one-time accounting charge ($358.2 million) when comparing 1993 and 1994 earnings to understand true operational growth.
• North America Trends: Investigate the causes of the 8% sales decline in North America (trade downstocking vs. structural demand issues) and the effectiveness of new product introductions.
• Debt Levels: Monitor the increased leverage (52% debt-to-capitalization) and the impact of the $1.04 billion Kolynos acquisition on future interest expenses and credit ratings.
• Acquisition Integration: Assess the integration progress of the Kolynos business and the realization of anticipated synergies in South America.
• Environmental Liabilities: Review the status of the Jeffersonville plant litigation and any potential future environmental costs.